Want to see OMDA full AI Analyst Report?
OMDA Stock Chart & Stats
$20.53
-$0.13(-0.63%)
At close: 4:00 PM EDT
$20.53
-$0.13(-0.63%)
Day’s Range― - ―
52-Week Range$10.28 - $26.92
Previous Close$18.29
Volume562.89K
Average Volume (3M)1.14M
Market Cap
$1.45B
Enterprise Value$1.18K
Total Cash (Recent Filing)$221.71M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)349.8
Beta2.06
Next Earnings
Nov 05, 2026EPS Estimate
0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding61,216,700
10 Day Avg. Volume1,187,912
30 Day Avg. Volume1,136,308
Financial Highlights & Ratios
PEG Ratio0.97
Price to Book (P/B)4.01
Price to Sales (P/S)3.54
P/FCF Ratio54.46
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$27.70Price Target Upside34.92% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)0.35
Revenue Forecast (FY)$336.63M
Bulls Say, Bears Say
Bulls Say
Strong Revenue And Membership GrowthSustained double‑digit revenue and member growth reflects expanding demand from employers and payers for Omada’s chronic‑care programs. Growth increases recurring contracted revenue, improves bargaining power with large customers, and raises potential lifetime value from larger, stickier cohorts.
Material Margin Expansion And Efficiency GainsHigher gross margins and meaningful cost‑to‑serve declines indicate improving unit economics and durable operating leverage. AI and scale improvements raise coach capacity and lower per‑member costs, supporting sustainable profitability as revenue grows and fixed costs spread.
Strong Balance Sheet And Improving Cash GenerationPositive operating and free cash flow after prior burn, coupled with no debt and sizable cash reserves, provides financial flexibility to fund growth, absorb execution hiccups, and invest in partnerships without near‑term refinancing risk, strengthening durability of operations.
Bears Say
Profitability Not Yet Proven Multi‑yearAlthough margins and GAAP profit improved recently, historical multi‑year profitability is not established. Reversion risks exist if growth slows or investments reaccelerate; sustained positive net income and ROE must be demonstrated to confirm durable earnings quality.
Execution Risk In Early-stage ChannelsRevenue upside depends on converting nascent PBM and prescribing partnerships into scaled, recurring channels. Early sales motions require sales execution, integration and proof points; delays or weaker conversion would slow growth and pressure forward margin assumptions.
GLP‑1 Employer Coverage UncertaintyDemand for Omada’s GLP‑1 prescribing track depends on employer coverage decisions that can change annually. Coverage variability creates structural demand volatility for a product line still a minority of members, making revenue and margin contribution from GLP‑1s less predictable.
Omada Health, Inc. News
OMDA FAQ
What was Omada Health, Inc.’s price range in the past 12 months?
Omada Health, Inc. lowest stock price was $10.28 and its highest was $26.91 in the past 12 months.
What is Omada Health, Inc.’s market cap?
Omada Health, Inc.’s market cap is $1.45B.
When is Omada Health, Inc.’s upcoming earnings report date?
Omada Health, Inc.’s upcoming earnings report date is Nov 05, 2026 which is in 77 days.
How were Omada Health, Inc.’s earnings last quarter?
Omada Health, Inc. released its earnings results on Aug 06, 2026. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.062 by $0.118.
Is Omada Health, Inc. overvalued?
According to Wall Street analysts Omada Health, Inc.’s price is currently Undervalued.
Does Omada Health, Inc. pay dividends?
Omada Health, Inc. does not currently pay dividends.
What is Omada Health, Inc.’s EPS estimate?
Omada Health, Inc.’s EPS estimate is 0.08.
How many shares outstanding does Omada Health, Inc. have?
Omada Health, Inc. has 61,216,700 shares outstanding.
What happened to Omada Health, Inc.’s price movement after its last earnings report?
Omada Health, Inc. reported an EPS of $0.18 in its last earnings report, beating expectations of $0.062. Following the earnings report the stock price went up 21.136%.
Which hedge fund is a major shareholder of Omada Health, Inc.?
Currently, no hedge funds are holding shares in OMDA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Omada Health, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$27.70 (34.92% Upside)
$27.70 (34.92% Upside)
Blogger Sentiment
Bullish
OMDA Sentiment 60%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 2.2M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 0.3%
Last 30 Days ▲ 2.9%
Last 30 Days ▲ 2.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
7.13%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
8.33%
Trailing 12-Months
Company Description
Omada Health, Inc.
Omada Health is an American virtual health company that delivers evidence-based digital programs designed to manage common chronic ailments, including cardiometabolic, musculoskeletal, and behavioral health conditions, offering continuous support that bridges the gap between in-person medical appointments.
OMDA Company Deck
OMDA Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: record revenue, significant margin expansion, profitability, rapid membership growth, AI-driven efficiency gains, product launches (GLP-1 prescribing, cholesterol), and raised full-year guidance. Noted risks include seasonal moderation in H2, employer uncertainty around GLP-1 coverage, early-stage channels that require execution, and some near-term margin moderation as investments annualize. Overall the positives are broad and material and management provided clear plans to scale and convert pipeline.View all OMDA earnings summariesOMDA Stock 12 Month Forecast
Average Price Target
$27.70
▲(34.92% Upside)
Technical Analysis
Teladoc
―
American Well
―
GoodRx Holdings
―
Privia Health Group
―
Hinge Health, Inc. Class A
―
Ownership Overview
3.61% Insiders
15.16% Mutual Funds
37.72% Other Institutional Investors
37.07% Public Companies and
Individual Investors